| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisals TA1105: Clascoterone for treating acne vulgaris in people 12 years and over (terminated appraisal) |
|
Medicine details |
|
| Medicine name | Clascoterone (Winlevi®) |
| Formulation | 10 mg/g cream |
| Reference number | 3853 |
| Indication | Treatment of acne vulgaris in people 12 years and over |
| Company | Glenmark Pharmaceuticals Ltd |
| BNF chapter | Skin |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| NICE guidance | TA1105: Clascoterone for treating acne vulgaris in people 12 years and over (terminated appraisal) |
| Further information The company have confirmed that they will not be submitting to AWMSG for appraisal (December 2025) |
|